Skip to content

HealthBreaking

Novartis drug pelacarsen does not reduce heart attacks or strokes in clinical trial

By

Coverage spectrum

Covered by 3 outlets, all left-leaning.

3 articles in total. The spectrum counts each outlet once and leaves opinion out. How we measure bias

Gloved clinician taking a patient's blood pressure with a cuff and stethoscope.
Image via NBC NewsHow images are chosenReport this image

CNN, NBC News and NPR report that pelacarsen, an experimental drug from Novartis designed to lower lipoprotein(a), a fat-carrying protein in the blood, did not reduce heart attacks, strokes or cardiovascular deaths in the Horizon clinical trial. The results were presented Saturday at the American Heart Association’s annual meeting. The outlets say the trial enrolled nearly 800 sites and that the drug also did not reduce procedures to open blocked arteries. Before the results, researchers had expected a positive outcome, and NBC News quotes them calling the result a massive blow to preventive cardiology.

Headline and summary written by Mantle’s AI from the coverage below, under published rules. Editors read every story. How this works

What happened

Key points

Each point shows who reports it, from Far Left to Far Right.

  1. The pelacarsen trial (Horizon) did not show a reduction in heart attacks or strokes.

    One side only: the leftReported byLeft3See the outletsHide the outlets
    Left
    CNN, NBC News, NPR
  2. The results were presented Saturday at the American Heart Association’s annual meeting.

    One side only: the leftReported byLeft2See the outletsHide the outlets
    Left
    CNN, NBC News
  3. The drug is designed to lower lipoprotein(a), a form of cholesterol that builds up in arteries.

    One side only: the leftReported byLeft2See the outletsHide the outlets
    Left
    CNN, NBC News
  4. The trial involved nearly 800 sites, and researchers said the result was a massive blow to preventive cardiology.

    One outletNBC News· Left

How each side tells it

Compare views

CNN, NBC News and NPR all report that pelacarsen did not reduce heart attacks or strokes in a large trial. As only left-side outlets appear in this sample, their coverage presents the result mainly as a surprise and a setback, with CNN and NBC using more dramatic language.

  • the left

    3 outlets

    All three headlines present the trial as a failure or setback, with CNN using the strongest wording (“flops”) and NPR the most neutral (“fails unexpectedly”).

    A promising drug for an inherited heart risk Loaded verb“flops”The verb “flops” adds a judgement of failure and ridicule beyond the trial result itself.More neutral: does not succeedDisagree with this highlight?, stunning doctors
    CNNLeftAll left-leaning headlines
  • the center

    No coverage yet

    No center outlet that Mantle follows has covered this story yet. That absence is part of the picture.

  • the right

    No coverage yet

    No right-leaning outlet that Mantle follows has covered this story yet. That absence is part of the picture.

The words they chose

Language to notice

Words that carry a judgement beyond the facts. Tap a highlighted word anywhere on the page to see why.

  • Left1

    flops

  • Center

    Has not covered this story.

  • Right

    Has not covered this story.

In the outlets’ own words

  • Loaded verb

    flopsMore neutral: does not succeed

    The verb “flops” adds a judgement of failure and ridicule beyond the trial result itself.

    A promising drug for an inherited heart risk flops, stunning doctors

    Used byCNN (Left)

Words quoted from someone else (1)Hide the quoted words

Loaded words that outlets reported someone else saying. They show what was said, not how the outlet chose to say it.

  • Sensational language

    Quoted

    massive blowMore neutral: a significant setback

    The phrase is a dramatic characterization of the trial result, even though it is attributed to researchers.

    …people who have high levels of lipoprotein(a) stunned researchers, who called it a massive blow to preventive cardiology.

    Quoted byNBC News (Left)

    These are unnamed researchers’s words. The outlets are reporting them.

See the full language guide

See for yourself

Side by side

What each side leads with and what it leaves out. Open a side to read its headlines.

From the left

3 outlets

Leads with

  • the drug’s failure on its key measure
  • surprise among doctors and researchers
  • the hopes placed in the drug
See the 3 headlines from the leftHide the headlines
  • CNNLeft

    A promising drug for an inherited heart risk Loaded verb“flops”The verb “flops” adds a judgement of failure and ridicule beyond the trial result itself.More neutral: does not succeedDisagree with this highlight?, stunning doctors

    In the course of scientific discovery, there are triumphant moments when researchers present their findings to a rapt audience that jumps to its feet for a standing ovation. …

  • The ‘slam dunk’ that wasn’t: Promising cholesterol drug fails to prevent heart attacks or stroke

    An experimental drug that held great promise in driving down a dangerous form of cholesterol didn’t show any measurable impact on heart attack or stroke in a clinical trial.

  • NPRLeft

    A promising new medicine against heart disease fails unexpectedly

    Doctors expected an experimental drug that lowers a common risk factor for heart attacks would save patients' lives. The medicine made no difference.

From the center

0 outlets

No center outlet that Mantle follows has covered this story yet. That absence is part of the picture.

From the right

0 outlets

No right-leaning outlet that Mantle follows has covered this story yet. That absence is part of the picture.

The stories you read build My Mix, a private picture of which sides cover the stories you choose, kept on this device. What is My Mix?

The left is Far Left and Left together. The right is Right and Far Right together. Every outlet keeps its own five-point rating.

Help someone else find the truth beneath the surface

Most people see one side of a story. Share this one, so they can see how every side is telling it and decide for themselves.

Email it
Embed

Show this story’s coverage card on your own site, blog or class page. It has the headline, who is covering it and a link back here, and it tracks nobody. See the card

Seen a mistake? Tell us what is wrong with this page